Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.

Lee YJ, Koch M, Karl D, Torres-Collado AX, Fernando NT, Rothrock C, Kuruppu D, Ryeom S, Iruela-Arispe ML, Yoon SS.

Cancer Res. 2010 Feb 1;70(3):948-56. doi: 10.1158/0008-5472.CAN-09-3094. Epub 2010 Jan 26.


Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39. doi: 10.1158/1078-0432.CCR-07-4126.


ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2.

Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF, Iruela-Arispe ML.

EMBO J. 2006 Nov 15;25(22):5270-83. Epub 2006 Nov 2.


ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors.

Gustavsson H, Tesan T, Jennbacken K, Kuno K, Damber JE, Welén K.

BMC Cancer. 2010 Jun 14;10:288. doi: 10.1186/1471-2407-10-288.


Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.

Veliceasa D, Ivanovic M, Hoepfner FT, Thumbikat P, Volpert OV, Smith ND.

FEBS J. 2007 Dec;274(24):6365-77. Epub 2007 Nov 15.


Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis.

Obika M, Ogawa H, Takahashi K, Li J, Hatipoglu OF, Cilek MZ, Miyoshi T, Inagaki J, Ohtsuki T, Kusachi S, Ninomiya Y, Hirohata S.

Cancer Sci. 2012 Oct;103(10):1889-97. doi: 10.1111/j.1349-7006.2012.02381.x. Epub 2012 Aug 29.


The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.

Ricciardelli C, Frewin KM, Tan Ide A, Williams ED, Opeskin K, Pritchard MA, Ingman WV, Russell DL.

Am J Pathol. 2011 Dec;179(6):3075-85. doi: 10.1016/j.ajpath.2011.08.021. Epub 2011 Oct 12.


Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.

Lee YJ, Karl DL, Maduekwe UN, Rothrock C, Ryeom S, D'Amore PA, Yoon SS.

Cancer Res. 2010 Nov 1;70(21):8357-67. doi: 10.1158/0008-5472.CAN-10-1138. Epub 2010 Oct 26.


Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.

Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano HJ, Okano H, Okada Y.

J Natl Cancer Inst. 2012 Jun 20;104(12):906-22. doi: 10.1093/jnci/djs232. Epub 2012 May 25.


Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.

Firlej V, Mathieu JR, Gilbert C, Lemonnier L, Nakhlé J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N, Delongchamps NB, Cabon F.

Cancer Res. 2011 Dec 15;71(24):7649-58. doi: 10.1158/0008-5472.CAN-11-0833. Epub 2011 Oct 28.


Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice.

Lawler J, Miao WM, Duquette M, Bouck N, Bronson RT, Hynes RO.

Am J Pathol. 2001 Nov;159(5):1949-56.


Aberrant methylation of ADAMTS1 in non-small cell lung cancer.

Choi JE, Kim DS, Kim EJ, Chae MH, Cha SI, Kim CH, Jheon S, Jung TH, Park JY.

Cancer Genet Cytogenet. 2008 Dec;187(2):80-4. doi: 10.1016/j.cancergencyto.2008.08.001.


Beta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.

Goel HL, Moro L, Murphy-Ullrich JE, Hsieh CC, Wu CL, Jiang Z, Languino LR.

Cancer Res. 2009 Jul 1;69(13):5374-82. doi: 10.1158/0008-5472.CAN-09-0186. Epub 2009 Jun 23.


Expression of ADAMTS1 and its correlation with angiogenesis in primary gastric cancer and lymph node metastasis.

Chen J, Zhi Y, Chang X, Zhang S, Dai D.

Dig Dis Sci. 2013 Feb;58(2):405-13. doi: 10.1007/s10620-012-2379-x. Epub 2012 Sep 22.


Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.

Olsson A, Björk A, Vallon-Christersson J, Isaacs JT, Leanderson T.

Mol Cancer. 2010 May 17;9:107. doi: 10.1186/1476-4598-9-107.


The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Sweetwyne MT, Pallero MA, Lu A, Van Duyn Graham L, Murphy-Ullrich JE.

Am J Pathol. 2010 Oct;177(4):1710-24. doi: 10.2353/ajpath.2010.090903. Epub 2010 Aug 19.


BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.

Tsuchida R, Osawa T, Wang F, Nishii R, Das B, Tsuchida S, Muramatsu M, Takahashi T, Inoue T, Wada Y, Minami T, Yuasa Y, Shibuya M.

Oncogene. 2014 Jul 17;33(29):3803-11. doi: 10.1038/onc.2013.358. Epub 2013 Sep 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk